Phase I, Dose-Escalation Study of Dihydromyricetin (DHM) to Treat Alcohol-Associated Liver Disease
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT05623501
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alcohol-Related Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Dihydromyricetin — DRUGDose-escalation and lysine preparation
Study Details
The current proposal is designed as a first-in-human Phase 1 open-label, dose-escalation study to assess the safety, pharmacokinetics, and the maximum tolerated dose of DHM among healthy volunteers using a purified form of DHM from a local cGMP compliant source (Master Herbs, Inc).
Key Dates
- Start date
- Sep 15, 2024
- Status verified
- Aug 2024
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Cohort 1DHM 300mg x1 dose
- Experimental: Cohort 2DHM 900mg x1 dose
- Experimental: Cohort 3DHM 300mg x1 dose + Lysine 140mg x1 dose
- Experimental: Cohort 4DHM 900mg x1 dose + Lysine 420mg x1 dose
Primary Outcome Measure
Pharmacokinetic of DHM [ Time Frame: -0.5 (pre-dose), 0 (1st dose), 0.5, 1, 2, 4, 6, 8 (2nd dose), 10, and 24 hours post-dose. ]
Central Contacts
- Brian Lee, MD323-442-5576
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90089 | Matthew Dukewich, MD |
Find similar trials in Los Angeles, CA
By research site
Related Studies
- Characterization Imaging Instruments in Alcoholics and Non-AlcoholicsRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver TransplantationEnrolling By Invitation · Johns Hopkins University · Baltimore, Maryland
- COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History StudyRecruiting · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Bethesda, Maryland
- Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive YearsRecruiting · Emory University · Boston, Massachusetts